menu
    • menu

    Company profile for AVID RADIOPHARMS INC

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to improve patient lives by developing molecular imaging agents to accelerate clinical development and improve clinical care.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AVID RADIOPHARMS INCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Avid Radiopharmaceuticals, Inc., 3711 Market Street, 7th floor Philadelphia,...
    Telephone
    Telephone
    215-298-0700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.avidrp.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avid Radiopharm`s Tauvid (flortaucipir (18F)) Receives Approval in Europe
    Avid Radiopharm`s Tauvid (flortaucipir (18F)) Receives Approval in Europe

    22 Aug 2024

    // EMA

    https://www.ema.europa.eu/en/documents/overview/tauvid-epar-medicine-overview_en.pdf

    EMA
    22 Aug 2024
    Share Share
    FDA approves Lilly's dye for mapping Alzheimer's tau tangles
    FDA approves Lilly's dye for mapping Alzheimer's tau tangles

    30 May 2020

    // Conor Hale FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/fda-approves-eli-lilly-s-tauvid-dye-its-first-for-mapping-alzheimer-s-tau-tangles

    Conor Hale FIERCE BIOTECH
    30 May 2020
    Share Share
    New Lilly Research Labs President Tweaks Company’s Approach to Drug Development
    New Lilly Research Labs President Tweaks Company’s Approach to Drug Development

    02 Apr 2018

    // Mark Terry BIOSPACE

    https://www.biospace.com/article/new-lilly-research-labs-president-tweaks-company-s-approach-to-drug-development/

    Mark Terry BIOSPACE
    02 Apr 2018
    Share Share
    Eli Lilly unit strengthens efforts to diagnose Alzheimer's
    Eli Lilly unit strengthens efforts to diagnose Alzheimer's

    17 Apr 2013

    // BIZJOURNALS

    https://www.bizjournals.com/philadelphia/news/2013/04/17/avid-to-work-on-alzheimers-traces.html

    BIZJOURNALS
    17 Apr 2013
    Share Share
    Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing
    Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing

    21 May 2009

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20090521005087/en/Avid-Radiopharmaceuticals-Closes-34.5-Million-Series-Financing

    BUSINESSWIRE
    21 May 2009
    Share Share
    Avid Radiopharmaceuticals Closes $26 Million Series C Financing
    Avid Radiopharmaceuticals Closes $26 Million Series C Financing

    21 May 2009

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20070509005353/en/Avid-Radiopharmaceuticals-Closes-26-Million-Series-Financing

    BUSINESSWIRE
    21 May 2009
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search